annual SGA:
$488.43M+$81.87M(+20.14%)Summary
- As of today (August 31, 2025), ACAD annual SGA is $488.43 million, with the most recent change of +$81.87 million (+20.14%) on December 31, 2024.
- During the last 3 years, ACAD annual SGA has risen by +$92.40 million (+23.33%).
- ACAD annual SGA is now at all-time high.
Performance
ACAD SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$126.37M(-100.00%)Summary
- As of today (August 31, 2025), ACAD quarterly SGA is $0.00, with the most recent change of -$126.37 million (-100.00%) on June 30, 2025.
- Over the past year, ACAD quarterly SGA has dropped by -$117.06 million (-100.00%).
- ACAD quarterly SGA is now -100.00% below its all-time high of $133.29 million, reached on September 30, 2024.
Performance
ACAD quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$8.90B+$222.16M(+2.44%)Summary
- As of today (August 31, 2025), ACAD TTM SGA is -$8.90 billion, with the most recent change of +$222.16 million (+2.44%) on June 30, 2025.
- Over the past year, ACAD TTM SGA has dropped by -$9.33 billion (-2147.99%).
- ACAD TTM SGA is now -12913.28% below its all-time high of -$68.37 million.
Performance
ACAD TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ACAD Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.1% | -100.0% | -2148.0% |
| 3 y3 years | +23.3% | -100.0% | -2459.8% |
| 5 y5 years | +50.0% | -100.0% | -2585.7% |
ACAD Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.3% | -100.0% | at low | -0.7% | +8.6% |
| 5 y | 5-year | at high | +50.0% | -100.0% | at low | -27.4% | +8.6% |
| alltime | all time | at high | >+9999.0% | -100.0% | at low | <-9999.0% | +8.6% |
ACAD Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $259.66M(-31.1%) |
| Mar 2025 | - | $126.37M(>+9900.0%) | $376.73M(+5.1%) |
| Dec 2024 | $488.43M(+20.1%) | $0.00(-100.0%) | $358.35M(-23.7%) |
| Sep 2024 | - | $133.29M(+13.9%) | $469.81M(+8.1%) |
| Jun 2024 | - | $117.06M(+8.4%) | $434.41M(+5.1%) |
| Mar 2024 | - | $107.99M(-3.1%) | $413.31M(+1.7%) |
| Dec 2023 | $406.56M(+10.2%) | $111.47M(+13.9%) | $406.56M(+1.8%) |
| Sep 2023 | - | $97.89M(+2.0%) | $399.50M(+5.2%) |
| Jun 2023 | - | $95.97M(-5.2%) | $379.71M(+1.6%) |
| Mar 2023 | - | $101.23M(-3.0%) | $373.65M(+1.2%) |
| Dec 2022 | $369.09M(-6.8%) | $104.40M(+33.7%) | $369.09M(-0.4%) |
| Sep 2022 | - | $78.11M(-13.1%) | $370.46M(-1.7%) |
| Jun 2022 | - | $89.90M(-7.0%) | $377.01M(-2.5%) |
| Mar 2022 | - | $96.68M(-8.6%) | $386.58M(-4.3%) |
| Dec 2021 | $396.03M(+1.9%) | $105.77M(+24.9%) | $404.07M(-3.6%) |
| Sep 2021 | - | $84.66M(-14.9%) | $419.05M(+0.1%) |
| Jun 2021 | - | $99.47M(-12.9%) | $418.78M(+3.1%) |
| Mar 2021 | - | $114.17M(-5.5%) | $406.23M(+2.5%) |
| Dec 2020 | $388.66M(+19.4%) | $120.75M(+43.1%) | $396.21M(+7.9%) |
| Sep 2020 | - | $84.39M(-2.9%) | $367.33M(+2.6%) |
| Jun 2020 | - | $86.92M(-16.5%) | $357.91M(+5.0%) |
| Mar 2020 | - | $104.15M(+13.4%) | $341.01M(+2.8%) |
| Dec 2019 | $325.64M(+22.5%) | $91.87M(+22.5%) | $331.58M(+5.1%) |
| Sep 2019 | - | $74.97M(+7.1%) | $315.55M(+4.1%) |
| Jun 2019 | - | $70.02M(-26.1%) | $303.20M(-0.3%) |
| Mar 2019 | - | $94.72M(+24.9%) | $304.17M(+11.9%) |
| Dec 2018 | $265.76M(+4.2%) | $75.84M(+21.1%) | $271.71M(+3.5%) |
| Sep 2018 | - | $62.63M(-11.8%) | $262.56M(+0.1%) |
| Jun 2018 | - | $70.99M(+14.0%) | $262.19M(+3.5%) |
| Mar 2018 | - | $62.26M(-6.6%) | $253.31M(-1.4%) |
| Dec 2017 | $255.06M(+36.8%) | $66.69M(+7.1%) | $256.80M(+3.6%) |
| Sep 2017 | - | $62.26M(+0.2%) | $247.77M(+5.0%) |
| Jun 2017 | - | $62.11M(-5.5%) | $236.05M(+5.0%) |
| Mar 2017 | - | $65.75M(+14.0%) | $224.71M(+20.5%) |
| Dec 2016 | $186.46M(+111.2%) | $57.66M(+14.1%) | $186.46M(+23.1%) |
| Sep 2016 | - | $50.53M(-0.5%) | $151.41M(+24.9%) |
| Jun 2016 | - | $50.77M(+84.7%) | $121.18M(+32.4%) |
| Mar 2016 | - | $27.49M(+21.6%) | $91.53M(+3.7%) |
| Dec 2015 | $88.30M(+169.6%) | $22.62M(+11.4%) | $88.30M(+16.0%) |
| Sep 2015 | - | $20.31M(-3.8%) | $76.11M(+19.2%) |
| Jun 2015 | - | $21.12M(-13.0%) | $63.86M(+26.0%) |
| Mar 2015 | - | $24.26M(+132.8%) | $50.69M(+54.8%) |
| Dec 2014 | $32.75M(+157.5%) | $10.42M(+29.3%) | $32.75M(+23.1%) |
| Sep 2014 | - | $8.06M(+1.3%) | $26.61M(+19.1%) |
| Jun 2014 | - | $7.95M(+25.8%) | $22.34M(+32.3%) |
| Mar 2014 | - | $6.32M(+47.8%) | $16.89M(+32.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $12.72M(+81.7%) | $4.28M(+12.6%) | $12.72M(+18.4%) |
| Sep 2013 | - | $3.80M(+52.1%) | $10.74M(+27.4%) |
| Jun 2013 | - | $2.50M(+16.0%) | $8.43M(+12.6%) |
| Mar 2013 | - | $2.15M(-6.4%) | $7.49M(+7.0%) |
| Dec 2012 | $7.00M(-8.0%) | $2.30M(+54.7%) | $7.00M(+13.3%) |
| Sep 2012 | - | $1.49M(-4.6%) | $6.18M(-0.5%) |
| Jun 2012 | - | $1.56M(-6.3%) | $6.21M(-0.2%) |
| Mar 2012 | - | $1.66M(+12.3%) | $6.22M(-3.5%) |
| Dec 2011 | $7.61M(+17.8%) | $1.48M(-2.7%) | $6.45M(-9.0%) |
| Sep 2011 | - | $1.52M(-3.1%) | $7.09M(-0.8%) |
| Jun 2011 | - | $1.57M(-16.8%) | $7.15M(+0.2%) |
| Mar 2011 | - | $1.88M(-11.0%) | $7.13M(+1.0%) |
| Dec 2010 | $6.46M(-37.2%) | $2.12M(+34.2%) | $7.06M(+42.8%) |
| Sep 2010 | - | $1.58M(+1.7%) | $4.94M(-7.8%) |
| Jun 2010 | - | $1.55M(-14.4%) | $5.36M(-17.2%) |
| Mar 2010 | - | $1.81M(>+9900.0%) | $6.47M(-15.4%) |
| Dec 2009 | $10.28M(-13.0%) | $0.00(-100.0%) | $7.64M(0.0%) |
| Sep 2009 | - | $1.99M(-25.1%) | $7.64M(-6.4%) |
| Jun 2009 | - | $2.66M(-10.9%) | $8.17M(-6.0%) |
| Mar 2009 | - | $2.99M(>+9900.0%) | $8.69M(-3.1%) |
| Dec 2008 | $11.82M(-3.7%) | $0.00(-100.0%) | $8.97M(0.0%) |
| Sep 2008 | - | $2.52M(-20.9%) | $8.97M(-4.5%) |
| Jun 2008 | - | $3.18M(-2.6%) | $9.39M(+0.2%) |
| Mar 2008 | - | $3.27M(>+9900.0%) | $9.37M(+1.3%) |
| Dec 2007 | $12.27M(+8.1%) | $0.00(-100.0%) | $9.26M(-21.5%) |
| Sep 2007 | - | $2.94M(-7.0%) | $11.79M(+5.1%) |
| Jun 2007 | - | $3.16M(+0.3%) | $11.21M(+8.4%) |
| Mar 2007 | - | $3.15M(+24.3%) | $10.35M(+9.2%) |
| Dec 2006 | $11.35M(-28.7%) | $2.54M(+7.3%) | $9.48M(-1.5%) |
| Sep 2006 | - | $2.36M(+3.0%) | $9.62M(-2.0%) |
| Jun 2006 | - | $2.30M(+0.5%) | $9.82M(-1.5%) |
| Mar 2006 | - | $2.28M(-14.7%) | $9.97M(+2.8%) |
| Dec 2005 | $15.91M(+119.6%) | $2.68M(+4.6%) | $9.69M(+5.6%) |
| Sep 2005 | - | $2.56M(+4.7%) | $9.18M(+6.7%) |
| Jun 2005 | - | $2.45M(+21.7%) | $8.60M(+12.4%) |
| Mar 2005 | - | $2.01M(-7.1%) | $7.65M(+5.6%) |
| Dec 2004 | $7.25M(+73.2%) | $2.16M(+9.3%) | $7.25M(+42.6%) |
| Sep 2004 | - | $1.98M(+32.5%) | $5.08M(+35.7%) |
| Jun 2004 | - | $1.49M(-7.0%) | $3.74M(+29.4%) |
| Mar 2004 | - | $1.61M(>+9900.0%) | $2.89M(+28.1%) |
| Dec 2003 | $4.18M(+5.1%) | $0.00(-100.0%) | $2.26M(0.0%) |
| Sep 2003 | - | $642.50K(-0.2%) | $2.26M(+39.8%) |
| Jun 2003 | - | $643.60K(-33.7%) | $1.61M(+66.3%) |
| Mar 2003 | - | $971.20K | $971.20K |
| Dec 2002 | $3.98M(+6.0%) | - | - |
| Dec 2001 | $3.76M(+25.2%) | - | - |
| Dec 2000 | $3.00M | - | - |
FAQ
- What is ACADIA Pharmaceuticals Inc. annual SGA?
- What is the all time high annual SGA for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. annual SGA year-on-year change?
- What is ACADIA Pharmaceuticals Inc. quarterly SGA?
- What is the all time high quarterly SGA for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. quarterly SGA year-on-year change?
- What is ACADIA Pharmaceuticals Inc. TTM SGA?
- What is the all time high TTM SGA for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. TTM SGA year-on-year change?
What is ACADIA Pharmaceuticals Inc. annual SGA?
The current annual SGA of ACAD is $488.43M
What is the all time high annual SGA for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high annual SGA is $488.43M
What is ACADIA Pharmaceuticals Inc. annual SGA year-on-year change?
Over the past year, ACAD annual SGA has changed by +$81.87M (+20.14%)
What is ACADIA Pharmaceuticals Inc. quarterly SGA?
The current quarterly SGA of ACAD is $0.00
What is the all time high quarterly SGA for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high quarterly SGA is $133.29M
What is ACADIA Pharmaceuticals Inc. quarterly SGA year-on-year change?
Over the past year, ACAD quarterly SGA has changed by -$117.06M (-100.00%)
What is ACADIA Pharmaceuticals Inc. TTM SGA?
The current TTM SGA of ACAD is -$8.90B
What is the all time high TTM SGA for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high TTM SGA is -$68.37M
What is ACADIA Pharmaceuticals Inc. TTM SGA year-on-year change?
Over the past year, ACAD TTM SGA has changed by -$9.33B (-2147.99%)